The design platform giant has not rulled out a float this year, despite worries about the impact of artificial intelligence ...
While dismissing criticism over the massive water consumption by AI data centres, Altman noted that concerns about the ...
AI is steadily moving into India’s BFSI sector, improving fraud checks and efficiency, but humans still remain the task masters ...
Synopsys stock analysis: wide moat, AI-driven chip complexity growth, and Ansys deal impact. Read more macro analysis here.
In an amendment to an SEC filing, Medtronic's Diabetes unit, MiniMed, today priced its planned initial public offering (IPO).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results